Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
US8598220B2 · kind B2 · utility
1Cited by
5References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2009 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Jul 27, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of formula (I)wherein variables X1, X2, Y, R1a, R1b, R2a, R2b, A1, A2, A3, and A4 are as defined in the description, and methods of use to treat pain, neuropathic pain, allodynia, pain associated with inflammation or an inflammatory disease, inflammatory hyperalgesia, bladder overactivity, and urinary incontinence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.